Cytomegalovirus Infections, Disorder of Transplanted Kidney
Conditions
Keywords
Immunosuppression, Cytomegalovirus, Renal Transplant, Atrophy/interstitial, Conversion of tacrolimus everolimus
Brief summary
The aim of this the study is to the assess whether the graft and patient survival, rejection rates and renal graft function after the first year will not differ between both study arms. The investigators will also the evaluate the reduction in the incidence of cytomegalovirus the and improvement of renal function of the everolimus after 1 year.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with BMI below 30, * first transplants with PRA \< 30, * no contraindication for induction Thymoglobuline, * age 18 years or younger than 70 years.
Exclusion criteria
* patients with a BMI above 30 * retransplantation * patients hypersensitized with PRA \> 30 * compared with Thymoglobulina indication for induction * age under 18 or over 70 years
Countries
Brazil